211 related articles for article (PubMed ID: 31373469)
1. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
Di Micco L; Mirenghi F; Morelli E; De Simone E
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
[TBL] [Abstract][Full Text] [Related]
2. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
3. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
De Botton S; Dombret H; Sanz M; Miguel JS; Caillot D; Zittoun R; Gardembas M; Stamatoulas A; Condé E; Guerci A; Gardin C; Geiser K; Makhoul DC; Reman O; de la Serna J; Lefrere F; Chomienne C; Chastang C; Degos L; Fenaux P
Blood; 1998 Oct; 92(8):2712-8. PubMed ID: 9763554
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
5. The "retinoic acid syndrome" in acute promyelocytic leukemia.
Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
[TBL] [Abstract][Full Text] [Related]
6. How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia.
Sanz MA; Montesinos P
Blood; 2014 May; 123(18):2777-82. PubMed ID: 24627526
[TBL] [Abstract][Full Text] [Related]
7. [All-trans retinoic acid syndrome. Case report and a review of the literature].
Carrillo-Esper R; Carvajal-Ramos R; Contreras-Domínguez V; Hernández-Aguilar C; Romano-Estrada L; Melo-Martínez C
Gac Med Mex; 2004; 140(5):547-52. PubMed ID: 15559237
[TBL] [Abstract][Full Text] [Related]
8. Differentiation syndrome in patients with acute promyelocytic leukemia.
Rogers JE; Yang D
J Oncol Pharm Pract; 2012 Mar; 18(1):109-14. PubMed ID: 21364078
[TBL] [Abstract][Full Text] [Related]
9. Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.
Collinge E; Tigaud I; Balme B; Gerland LM; Sujobert P; Carlioz V; Salles G; Thomas X; Paubelle E
Medicine (Baltimore); 2018 Feb; 97(8):e9657. PubMed ID: 29465554
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
[TBL] [Abstract][Full Text] [Related]
11. A case of life-threatening retinoic acid syndrome and review of literature.
Tariq Z; Phinney RC; Mohamed I
Am J Ther; 2014; 21(2):e28-30. PubMed ID: 23567795
[TBL] [Abstract][Full Text] [Related]
12. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
13. Perioperative retinoic acid syndrome in a patient with acute promyelocytic leukemia.
Usoltsev NA; Dhamee MS
J Clin Anesth; 2012 Jun; 24(4):315-7. PubMed ID: 22608587
[TBL] [Abstract][Full Text] [Related]
14. Differentiation syndrome with lower-intensity treatments for acute myeloid leukemia.
Fathi AT; Stein EM; DiNardo CD; Levis MJ; Montesinos P; de Botton S
Am J Hematol; 2021 Jun; 96(6):735-746. PubMed ID: 33625753
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary corroboration in differentiation syndrome: a case report.
Sarkar S; Ghosh P; Gehani A; Ghara N; Bhattacharyya P
J Med Case Rep; 2021 May; 15(1):226. PubMed ID: 33947461
[TBL] [Abstract][Full Text] [Related]
16. Recurrent differentiation syndrome or septic shock? Unresolved dilemma in a patient with acute promyelocytic leukemia.
Jeddi R; Ghédira H; Amor RB; Menif S; Belhadjali Z; Meddeb B
Med Oncol; 2011 Mar; 28(1):279-81. PubMed ID: 20204541
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
Yamamoto de Almeida L; Pereira-Martins DA; Lima ASG; Baggio MS; de Araujo Koury LC; Lange AP; Bassi SC; Scheucher PS; Rego EM
BMC Cancer; 2020 Aug; 20(1):821. PubMed ID: 32859169
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid syndrome: manifestations, pathogenesis, and treatment.
Larson RS; Tallman MS
Best Pract Res Clin Haematol; 2003 Sep; 16(3):453-61. PubMed ID: 12935962
[TBL] [Abstract][Full Text] [Related]
19. Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia.
Flombaum CD; Isaacs M; Reich L; Berman E; Warrell RP
Am J Kidney Dis; 1996 Jan; 27(1):134-7. PubMed ID: 8546128
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid syndrome in acute promyelocytic leukemia.
Sentero D; Hosenpud J
Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
